Mehri Sadri McKellar, MD

Associate Professor of Medicine
Campus mail Duke Box 102359, Durham, NC 27710
Phone (919) 613-6129
Email address mehri.mckellar@duke.edu

Education and Training

  • Infectious Diseases Fellow, Medicine, University of Utah, 2003 - 2006
  • Resident, Medicine, University of Utah, 2000 - 2003
  • M.D., University of Arizona, 2000

Publications

Gay, Cynthia L., Dayna T. Neo, Aaron S. Devanathan, Joann D. Kuruc, Kara S. McGee, John L. Schmitz, Joe Sebastian, et al. “Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.” Aids 34, no. 13 (November 1, 2020): 1923–31. https://doi.org/10.1097/QAD.0000000000002652.

PMID
32773474
Full Text

Towe, Sheri L., Catherine A. Sullivan, Mehri S. McKellar, and Christina S. Meade. “Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States.” Aids Behav, August 5, 2020. https://doi.org/10.1007/s10461-020-02987-y.

PMID
32757101
Full Text

Zhang, Helen L., Bhavini Murthy, Barbara Johnston, Marissa Mortiboy, Jiewei Wu, Gregory P. Samsa, Arlene C. Seña, and Mehri S. McKellar. “Public Awareness of HIV Pre-Exposure Prophylaxis in Durham, North Carolina: Results of a Community Survey.” N C Med J 80, no. 1 (January 2019): 7–11. https://doi.org/10.18043/ncm.80.1.7.

PMID
30622197
Full Text

Eron, Joseph J., Jean-Daniel Lelievre, Robert Kalayjian, Jihad Slim, Anson K. Wurapa, Jeffrey L. Stephens, Cheryl McDonald, et al. “Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial.” Lancet Hiv, December 13, 2018. https://doi.org/10.1016/S2352-3018(18)30296-0.

PMID
30555051
Full Text

Safeek, Rachel H., Katherine S. Hall, Felipe Lobelo, Carlos Del Rio, Audrey L. Khoury, Tammy Wong, Miriam C. Morey, and Mehri S. McKellar. “Low Levels of Physical Activity Among Older Persons Living with HIV/AIDS Are Associated with Poor Physical Function.” Aids Res Hum Retroviruses 34, no. 11 (November 2018): 929–35. https://doi.org/10.1089/AID.2017.0309.

PMID
29984584
Full Text

McGee, Kara S., Nwora Lance Okeke, Christopher B. Hurt, and Mehri S. McKellar. “Canary in the Coal Mine? Transmitted Mutations Conferring Resistance to All Integrase Strand Transfer Inhibitors in a Treatment-Naive Patient.” Open Forum Infect Dis 5, no. 11 (November 2018): ofy294. https://doi.org/10.1093/ofid/ofy294.

PMID
30515433
Full Text

Mitchell, John T., Sara LeGrand, Lisa B. Hightow-Weidman, Mehri S. McKellar, Angela Dm Kashuba, Mackenzie Cottrell, Tony McLaurin, Goutam Satapathy, and F Joseph McClernon. “Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial.” Jmir Mhealth Uhealth 6, no. 9 (September 10, 2018): e10456. https://doi.org/10.2196/10456.

PMID
30201601
Full Text

Thaden, Joshua T., Monica Gandhi, Hideaki Okochi, Christopher B. Hurt, and Mehri S. McKellar. “Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.” Aids 32, no. 9 (June 1, 2018): F1–4. https://doi.org/10.1097/QAD.0000000000001825.

PMID
29683856
Full Text

Clement, Meredith E., Jessica Seidelman, Jiewei Wu, Kareem Alexis, Kara McGee, N Lance Okeke, Gregory Samsa, and Mehri McKellar. “An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S.” Aids Care 30, no. 5 (May 2018): 650–55. https://doi.org/10.1080/09540121.2017.1384534.

PMID
28971705
Full Text

Okeke, Nwora Lance, Meredith E. Clement, Mehri S. McKellar, and Jason E. Stout. “Health Care Utilization Behaviors Predict Disengagement From HIV Care: A Latent Class Analysis.” Open Forum Infect Dis 5, no. 5 (May 2018): ofy088. https://doi.org/10.1093/ofid/ofy088.

PMID
29876365
Full Text

Pages